216 related articles for article (PubMed ID: 21220252)
21. beta-Blocker therapy in veterans with asthma or chronic obstructive pulmonary disease.
Barnett MJ; Milavetz G; Kaboli PJ
Pharmacotherapy; 2005 Nov; 25(11):1550-9. PubMed ID: 16232018
[TBL] [Abstract][Full Text] [Related]
22. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
[TBL] [Abstract][Full Text] [Related]
23. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
Kountz DS
Postgrad Med; 2009 Jan; 121(1):14-24. PubMed ID: 19179810
[TBL] [Abstract][Full Text] [Related]
24. Comorbidities of chronic obstructive pulmonary disease.
Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
[TBL] [Abstract][Full Text] [Related]
25. Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease.
Au DH; Bryson CL; Fan VS; Udris EM; Curtis JR; McDonell MB; Fihn SD
Am J Med; 2004 Dec; 117(12):925-31. PubMed ID: 15629731
[TBL] [Abstract][Full Text] [Related]
26. [Chronic obstructive pulmonary disease and coronary heart disease: approaches to the treatment of combined pathology].
Bova AA; Lapitskiĭ DV
Klin Med (Mosk); 2009; 87(2):8-13. PubMed ID: 19348292
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
Matera MG; Martuscelli E; Cazzola M
Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
[TBL] [Abstract][Full Text] [Related]
28. Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis.
van Gestel YR; Hoeks SE; Sin DD; Welten GM; Schouten O; Witteveen HJ; Simsek C; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
Am J Respir Crit Care Med; 2008 Oct; 178(7):695-700. PubMed ID: 18565952
[TBL] [Abstract][Full Text] [Related]
29. Respiratory stimulant use in chronic obstructive pulmonary disease.
Bales MJ; Timpe EM
Ann Pharmacother; 2004 Oct; 38(10):1722-5. PubMed ID: 15316108
[TBL] [Abstract][Full Text] [Related]
30. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
31. Disease modification in chronic obstructive pulmonary disease.
Anzueto A
Clin Chest Med; 2007 Sep; 28(3):609-16,vii. PubMed ID: 17720047
[TBL] [Abstract][Full Text] [Related]
32. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
Du Q; Sun Y; Ding N; Lu L; Chen Y
PLoS One; 2014; 9(11):e113048. PubMed ID: 25427000
[TBL] [Abstract][Full Text] [Related]
33. Beta-agonists, beta-blockers and obstructive airway disease.
Madalena Esteves M
Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
[No Abstract] [Full Text] [Related]
34. β-Blockers and chronic obstructive pulmonary disease: inappropriate avoidance?
Minor DS; Meyer AM; Long RC; Butler KR
J Clin Hypertens (Greenwich); 2013 Dec; 15(12):925-30. PubMed ID: 24102872
[TBL] [Abstract][Full Text] [Related]
35. The 'double dip' hypothesis: simultaneous prevention of cardiovascular and pulmonary morbidity and mortality using angiotensin II type 1 receptor blockers.
Mancini GB
Can J Cardiol; 2005 May; 21(6):519-23. PubMed ID: 15917881
[TBL] [Abstract][Full Text] [Related]
36. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
Chen AM; Bollmeier SG; Finnegan PM
Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
[TBL] [Abstract][Full Text] [Related]
37. A continued role for beta-blocker therapy in heart failure.
Korczyk DP; Doughty RN
Heart Fail Monit; 2006; 5(1):15-9. PubMed ID: 16547531
[TBL] [Abstract][Full Text] [Related]
38. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety.
Tashkin DP
Curr Opin Pulm Med; 2010 Mar; 16(2):97-105. PubMed ID: 20019615
[TBL] [Abstract][Full Text] [Related]
39. Beta-blockers: a new therapy in congestive heart failure.
Meghani SH; Becker D
Am J Crit Care; 2001 Nov; 10(6):417-27; quiz 428-9. PubMed ID: 11688609
[TBL] [Abstract][Full Text] [Related]
40. Beta-blockers in COPD: A systematic review based on recent research.
Li XF; Mao YM
Life Sci; 2020 Jul; 252():117649. PubMed ID: 32275936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
